Eleven Biotherapeutics Inc


Company Update (NASDAQ:EBIO): Eleven Biotherapeutics Inc Shareholders Cheer Viventia Acquisition

Eleven Biotherapeutics Inc (NASDAQ:EBIO) shares rose over 11% this morning after the company entered into a definitive share purchase agreement under which Eleven Biotherapeutics …

Monday Morning’s Market Insights: LinkedIn Corp (LNKD), Eleven Biotherapeutics Inc (EBIO), MannKind Corporation (MNKD), Sunesis Pharmaceuticals, Inc. (SNSS)

LinkedIn Corp (NYSE:LNKD) is up a whopping 48% after Microsoft agreed to buy the company for $26.2 billion in cash.

Analysts Weigh In on Three Biotech Stocks: Sarepta Therapeutics Inc (SRPT), Galena Biopharma Inc (GALE), Eleven Biotherapeutics Inc (EBIO)

The biotech sector has had a cruel start to the year. The Nasdaq Biotechnology Index (IBB) is down 19% so far in 2016, …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts